Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel P Trefny

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Science Translational Medicine|July 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunityNicole Kirchhammer, Marcel P Trefny, Marina Natoli, et al.
Cell Reports. Medicine|April 12, 2023
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancerPriska Auf der Maur, Marcel P Trefny, Zora Baumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung CancerMarcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Nature Communications|February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Science Translational Medicine|July 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunityNicole Kirchhammer, Marcel P Trefny, Marina Natoli, et al.
Cell Reports. Medicine|April 12, 2023
N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancerPriska Auf der Maur, Marcel P Trefny, Zora Baumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2019
A Variant of a Killer Cell Immunoglobulin-like Receptor Is Associated with Resistance to PD-1 Blockade in Lung CancerMarcel P Trefny, Sacha I Rothschild, Franziska Uhlenbrock, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Immunity|December 16, 2018
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, et al.
Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.
Nature Communications|February 2, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapyMarcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Science Immunology|June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancerClara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Nature Biomedical Engineering|February 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumoursJanina Dörr, Lisa Gregor, Sebastian B Lacher, et al.
Cell|January 20, 2022
Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T cell effector functionJonas Lötscher, Adrià-Arnau Martí I Líndez, Nicole Kirchhammer, et al.
Pageof 3